Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

[Extranodal marginal zone non Hodgkin's lymphoma of the lung: a ten-year experience].

Milosević V, Bogdanović A, Janković S, Jovanović MP, Mihaljević B.

Vojnosanit Pregl. 2011 Feb;68(2):150-4. Serbian.

PMID:
21456308
2.

Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease.

Ahmed S, Kussick SJ, Siddiqui AK, Bhuiya TA, Khan A, Sarewitz S, Steinberg H, Sison CP, Rai KR.

Eur J Cancer. 2004 Jun;40(9):1320-6.

PMID:
15177490
3.

[Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].

Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.

Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):345-8. Serbian.

PMID:
9863405
4.

Outcome and prognostic factors in ocular adnexal lymphoma.

Nola M, Lukenda A, Bollmann M, Kalauz M, Petrovecki M, Bollmann R.

Croat Med J. 2004 Jun;45(3):328-32.

5.

[Therapeutic management of central nervous system lymphomas in a single hematological institute].

Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.

Orv Hetil. 2009 Oct 18;150(42):1937-44. doi: 10.1556/OH.2009.28703. Hungarian.

PMID:
19812012
6.

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.

Younes A, Thieblemont C, Morschhauser F, Flinn I, Friedberg JW, Amorim S, Hivert B, Westin J, Vermeulen J, Bandyopadhyay N, de Vries R, Balasubramanian S, Hellemans P, Smit JW, Fourneau N, Oki Y.

Lancet Oncol. 2014 Aug;15(9):1019-26. doi: 10.1016/S1470-2045(14)70311-0. Epub 2014 Jul 17.

PMID:
25042202
7.

Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.

Abdelhamid T, Samra M, Ramadan H, Mehessin M, Mokhtar N.

J Egypt Natl Canc Inst. 2011 Mar;23(1):17-24. doi: 10.1016/j.jnci.2011.07.003. Epub 2011 Sep 8.

8.

Stage I and II MALT lymphoma: results of treatment with radiotherapy.

Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, Crump M.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1258-64.

PMID:
11483337
9.

Orbital lymphoma: diagnostic approach and treatment outcome.

Eckardt AM, Lemound J, Rana M, Gellrich NC.

World J Surg Oncol. 2013 Mar 18;11:73. doi: 10.1186/1477-7819-11-73.

10.

Treatment results of tonsillar lymphoma: a 10-year experience.

Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N.

Ann Hematol. 2005 Apr;84(4):223-6. Epub 2004 Mar 23.

PMID:
15042316
11.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
12.

Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.

McMaster ML, Greer JP, Wolff SN, Johnson DH, Greco FA, Stein RS, Cousar JB, Flexner JM, Hainsworth JD.

Cancer. 1991 Jul 15;68(2):233-41.

PMID:
1712662
13.

Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.

Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-López AJ.

J Clin Oncol. 2004 Dec 1;22(23):4711-6. Epub 2004 Oct 13. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15483015
14.

Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.

Aguiar-Bujanda D, Llorca-Mártinez I, Rivero-Vera JC, Blanco-Sánchez MJ, Jiménez-Gallego P, Mori-De Santiago M, Limeres-Gonzalez MA, Cabrera-Marrero JC, Hernández-Sosa M, Galván-Ruíz S, Hernández-Sarmiento S, Saura Grau S, Bohn-Sarmiento U.

Hematol Oncol. 2014 Sep;32(3):139-44. doi: 10.1002/hon.2105. Epub 2013 Oct 9.

PMID:
24123108
15.

[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].

Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.

Ai Zheng. 2006 Apr;25(4):465-70. Chinese.

PMID:
16613682
16.

[Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].

López-Guillermo A, García-Conde J, Alvarez-Carmona AM, León P, Maldonado J, Alcalá A, Zubizarreta A, Sancho-Tello R, Carbonell F, Contreras E, Besses C, Hernando A, Fontanillas M, Montserrat E.

Med Clin (Barc). 1998 May 9;110(16):601-4. Spanish.

PMID:
9656196
17.

[Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].

Hoederath A, Sack H, Stuschke M, Lampka E.

Strahlenther Onkol. 1996 Jul;172(7):356-66; discussion 367-8. German.

PMID:
8693402
18.

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.

Voulgarelis M, Giannouli S, Anagnostou D, Tzioufas AG.

Rheumatology (Oxford). 2004 Aug;43(8):1050-3. Epub 2004 Jun 8.

PMID:
15187246
19.

[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].

Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):486-9. Chinese.

PMID:
16613686
20.

Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.

Bailey EM, Ferry JA, Harris NL, Mihm MC Jr, Jacobson JO, Duncan LM.

Am J Surg Pathol. 1996 Aug;20(8):1011-23.

PMID:
8712288

Supplemental Content

Support Center